About Numeri
Numeri is a company based in Tortola (British Virgin Islands) founded in 2020. Numeri offers products and services including Venture Funds and Income Funds.
- Headquarter Tortola, British Virgin Islands
- SectorsHealthcareFinancial Services
- Social LinkedIn
- Legal Name Numeri
Products & Services of Numeri
Numeri offers a comprehensive portfolio of products and services, including Venture Funds and Income Funds.
Venture funds are offered for investing in innovative startups across various stages to facilitate growth and diversification
Income funds are provided for exposure to income-generating opportunities with high liquidity and risk management
Similar companies to Numeri
10 companies that operate in the same segment as Numeri (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Numeri
Numeri was founded in 2020.
Numeri is headquartered in Tortola, British Virgin Islands.
Numeri is identified as a venture capital firm that invests in disruptive innovations, including artificial intelligence, cloud computing, blockchain, biotech, and genomics, to back startups and ecosystems. It is noted for providing funding and operational support to enable exponential scaling, with a focus on sectors valued at 210 trillion by 2030. Security protocols are employed to protect assets, and various funds are managed to generate returns and diversify portfolios, fostering long-term growth for investors.
Numeri offers Venture Funds and Income Funds.
Numeri operates through Numeri.